[1] Perin J, Mai CT, De Costa A, Strong K, Diaz T, Blencowe H, et al. Systematic estimates of the global, regional and national under-5 mortality burden attributable to birth defects in 2000–2019: a summary of findings from the 2020 WHO estimates. BMJ Open 2023;13(1):e067033. http://dx.doi.org/10.1136/bmjopen-2022-067033CrossRef
[2] Perin J, Mulick A, Yeung D, Villavicencio F, Lopez G, Strong KL, et al. Global, regional, and national causes of under-5 mortality in 2000-19: an updated systematic analysis with implications for the Sustainable Development Goals. Lancet Child Adolesc Health 2022;6(2):106 − 15. http://dx.doi.org/10.1016/S2352-4642(21)00311-4CrossRef
[3] World Health Organization. The global burden of disease: 2004 update. Geneva: World Health Organization; 2008. https://www.who.int/publications/i/item/9789241563710.https://www.who.int/publications/i/item/9789241563710
[4] Spector LG, Kochilas L. Major birth defects and cancer. BMJ 2020;371:m4464. http://dx.doi.org/10.1136/bmj.m4464CrossRef
[5] Qin H, Zhu J. Birth defect prevention report: report on birth defects prevention and treatment in China (2012). 2013. https://www.gov.cn/govweb/gzdt/att/att/site1/20120912/1c6f6506c7f811bacf9301.pdf.https://www.gov.cn/govweb/gzdt/att/att/site1/20120912/1c6f6506c7f811bacf9301.pdf
[6] Chen GX, Zeng GZ, Chen XZ, Wu LS. Meta analysis for surveillance of mortality among children under 5 years old in China from 2001 to 2010. Chin J Healthy Birth Child Care 2013;19(8):619-21. https://d.wanfangdata.com.cn/periodical/zgysyy201308004. (In Chinese). https://d.wanfangdata.com.cn/periodical/zgysyy201308004
[7] Zhou Y, Mao XQ, Zhou H, Wang L, Qin ZQ, Cai ZM, et al. Birth defects data from population-based birth defects surveillance system in a district of southern Jiangsu, China, 2014–2018. Front Public Health 2020;8:378. http://dx.doi.org/10.3389/fpubh.2020.00378CrossRef
[8] Xie DH, Yang TB, Liu ZY, Wang H. Epidemiology of birth defects based on a birth defect surveillance system from 2005 to 2014 in Hunan Province, China. PLoS One 2016;11(1):e0147280. http://dx.doi.org/10.1371/journal.pone.0147280CrossRef
[9] Zhou TJ, Liu WX, Zhao ZL, Zhang G, Liu JT, He LK, et al. Changes in the incidence of birth defects in Sichuan Province, southwest China from 2006 to 2019: a retrospective analysis based on hospital birth defect monitoring. Res Square 2021;2(23):271811. http://dx.doi.org/10.21203/rs.3.rs-271811/v1CrossRef
[10] Zhang XG, Su L, Wu SQTY, Hao XJ, Guo SY, Suzuki K, et al. Prevalence of birth defects and risk-factor analysis from a population-based survey in Inner Mongolia, China. BMC Pediatr 2012;12(1):125. http://dx.doi.org/10.1186/1471-2431-12-125CrossRef
[11] Cui MM, Lu XL, Lu YY, Wang F, Xie XL, Cheng XY, et al. Knowledge and intake of folic acid to prevent neural tube defects among pregnant women in urban China: a cross-sectional study. BMC Pregnancy Childbirth 2021;21(1):432. http://dx.doi.org/10.1186/s12884-021-03893-4CrossRef
[12] Luo YL, Li CY, Gao XH, Tan SQ, Li JM, Wang W, et al. Maternal age, parity and isolated birth defects: a population-based case-control study in Shenzhen, China. PLoS One 2013;8(11):e81369. http://dx.doi.org/10.1371/journal.pone.0081369CrossRef
[13] van der Linde D, Konings EEM, Slager MA, Witsenburg M, Helbing WA, Takkenberg JJM, et al. Birth prevalence of congenital heart disease worldwide: a systematic review and meta-analysis. J Am Coll Cardiol 2011;58(21):2241 − 7. http://dx.doi.org/10.1016/j.jacc.2011.08.025CrossRef
[14] GBD 2017 Congenital Heart Disease Collaborators. Global, regional, and national burden of congenital heart disease, 1990–2017: a systematic analysis for the Global Burden of Disease Study 2017. Lancet Child Adolesc Health 2020;4(3):185 − 200. http://dx.doi.org/10.1016/S2352-4642(19)30402-XCrossRef
[15] De Wals P, Tairou F, Van Allen MI, Uh SH, Lowry RB, Sibbald B, et al. Reduction in neural-tube defects after folic acid fortification in Canada. N Engl J Med 2007;357(2):135 − 42. http://dx.doi.org/10.1056/NEJMoa067103CrossRef